Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant Vs Standard Adjuvant Endocrine Therapy in Patients Who Have Previously Received 2 to 5 Years of Adjuvant Endocrine Therapy for
Sponsored by Lilly USA, LLC
Active
$556.9K Funding
1 People
External
Related Topics
breast cancer,
adjuvant therapy,
immunotherapy,
clinical trial,
hormone receptor
People
Octavio Castanos
(CD)
Cancer Center Division
﹒Research Compliance Administrator II
